Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy.
about
Hippo/YAP pathway for targeted therapyAnti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma.Simvastatin modulates mesenchymal stromal cell proliferation and gene expressionLovastatin prevents bleomycin-induced DNA damage to HepG2 cells.
P2860
Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Differential effects of lovast ...... ells: implication for therapy.
@ast
Differential effects of lovast ...... ells: implication for therapy.
@en
Differential effects of lovast ...... ells: implication for therapy.
@nl
type
label
Differential effects of lovast ...... ells: implication for therapy.
@ast
Differential effects of lovast ...... ells: implication for therapy.
@en
Differential effects of lovast ...... ells: implication for therapy.
@nl
prefLabel
Differential effects of lovast ...... ells: implication for therapy.
@ast
Differential effects of lovast ...... ells: implication for therapy.
@en
Differential effects of lovast ...... ells: implication for therapy.
@nl
P2093
P2860
P1433
P1476
Differential effects of lovast ...... ells: implication for therapy.
@en
P2093
Emanuela Felley-Bosco
Rolf A Stahel
Thomas M Marti
Yandong Shi
P2860
P304
P356
10.1371/JOURNAL.PONE.0045354
P407
P577
2012-09-17T00:00:00Z